Abiraterone (Abiraterone 250drl, Teronred)
Abiraterone
Dr Reddyæs Laboratories (Pty) Ltd
Registration
- Applicant
- Dr Reddyæs Laboratories (Pty) Ltd
- Certificate holder
- Dr. Reddy’s Laboratories (Pty) Ltd.
- Registrations
- 3
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Abiraterone 250drl EACH TABLET CONTAINS: ABIRATERONE ACETATE 250,0 mg | 250 mgFilm-coated tablets. | 50085750/21.12/0857Approved 28 March 2025 | Registered | S4 | PIPIL |
| Teronred 250 EACH TABLET CONTAINS: ABIRATERONE ACETATE 250,0 mg | 250 mgFilm-coated tablets. | 51073251/21.12/0732Approved 28 March 2025 | Registered | S4 | PIPIL |
| Teronred 500 EACH TABLET CONTAINS ABIRATERONE ACETATE 500,0 mg | 500 mgFilm-coated tablets. | 56071556/21.12/0715Approved 10 March 2025 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Abiraterone acetate
S4: Abiraterone
Consolidated Schedules 06 July 2026, line 5131
Pharmacological class: Hormone inhibitors. (class 21.12)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
[(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
Drag to rotate. Structure from PubChem CID 9821849.
SAHPRA documents
Schedule Verification
This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.